about
International network of cancer genome projects.Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvementFNH-like nodules: Possible precursor lesions in patients with focal nodular hyperplasia (FNH)Association of adenoma and focal nodular hyperplasia: experience of a single French academic centerHypervascular nodule in a fibrotic liver overloaded with iron: identification of a premalignant area with preserved liver architecture.Plasma and Liver Hepatitis C Virus Variability in Patients Coinfected with Human Immunodeficiency VirusBi-allelic inactivation of TCF1 in hepatic adenomasMicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutationsGenotype phenotype classification of hepatocellular adenomaIntegration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomasIntegrative quantitative proteomics unveils proteostasis imbalance in human hepatocellular carcinoma developed on nonfibrotic livers.Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity.Evaluation of liver tumors using acoustic radiation force impulse elastography and correlation with histologic data.Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C.Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study.Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damageHNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines.Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism.A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.Hepatocellular Adenomas: Morphology and Genomics.Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma.Hepatic steatosis estimated microscopically versus digital image analysis.Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomasBRAF V600E mutational status in bile duct adenomas and hamartomas.Determination of DNA ploidy by fluorescence in situ hybridization (FISH) in hydatidiform moles: evaluation of FISH on isolated nuclei.Innervation of the sinusoidal wall: regulation of the sinusoidal diameter.Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.Hepatocellular adenomas associated with hepatic granulomas: experience in five cases.Over-expression of glutamine synthase in focal nodular hyperplasia (part 1): early stages in the formation support the hypothesis of a focal hyper-arterialisation with venous (portal and hepatic) and biliary damage.Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens.Expression of fibrillin-1 in focal nodular hyperplasia of the liver: a role in microcirculation adaptability.Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context.Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification.Benign hepatocellular tumors: a multidisciplinary approach.Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesionsTransient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence.Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
P50
Q24611474-112A32A9-51FE-41FE-9679-2F2BC448A379Q24671145-657FB43F-A367-4D07-A3F7-1561DCCAAF29Q24791036-D351518E-4FF3-4E99-A3DE-612BDDF35AC9Q24802860-4151214C-0C84-4D34-8FD5-0CAB2C94BB8DQ24803915-39A63100-09E7-4E71-AC2B-E68B08531657Q27473249-04072E8B-85AD-41F6-A76A-16B33A35DDA0Q28204646-8C535494-D0BF-494D-8EC3-065D0107DE31Q28277590-EFB27BA8-E03D-4D6C-82AE-48FD9D568F28Q28306241-8DB17C89-B580-4B51-B486-FFC2F69B04E7Q28649881-642637B9-D260-43BC-BD88-ED1F190F487CQ30397531-B8DD9A7D-D50C-4F47-8609-B4A4270A9B1FQ30460181-0D31FA6A-11BB-46A7-8080-DDC580844CA1Q30583367-C6AF858C-00C6-496E-9E10-612D745AF17FQ33221629-89369C42-F4E1-4A99-AF62-590D709CE232Q33866459-F53F9624-2999-4460-9659-B6AB017A4F60Q33930343-F098B3C0-6C65-4487-86CD-CDBAEF4FFBBAQ34040991-8F81D6A9-3AAB-4C5A-8506-DAD0DBF9968CQ34080748-FD453699-D3BE-4CBE-B616-CFA142F93CE7Q34292415-B799D878-FD91-4003-BAF2-41EEC2DAEBDDQ34556768-CA764656-20D2-4BBA-BC81-8AD852EF2E32Q34618992-72255FF2-056B-427C-B7CF-AEC655766659Q34656764-6BE59C16-F8AB-478C-8855-445D12F9B159Q35102345-45727EDB-EECF-4FD0-B4A8-C0CD502CBADDQ35565384-4DA3F18D-D877-479C-B3FB-484BCB6EC5FFQ35799487-FA4D104D-F929-4318-B39A-B47F3D63311AQ35894498-601D8C15-976A-473C-987F-4F7287CB6087Q36104399-7E2DC98C-2B5F-412B-95F1-9A56C6E63475Q36300686-97B70683-F445-434B-A3F8-CF644C85650EQ36413812-B4B88405-96E7-4FF8-B36A-4E73070CF542Q36422704-690ECAEF-95B7-4479-B067-AC44124AD68EQ36539135-C20BE8E1-5936-4708-9473-F796DD64C5D4Q36663499-021C4B97-09F6-4EAC-B9F6-AD31FE52A707Q36694023-DBFDFD9A-D1BA-4F0E-B368-7A00C20B1FB8Q36838371-F625468D-889F-4AB7-AAE5-D04A63294737Q36845481-AE3DE995-F195-4DD6-825F-AEECB9F101C0Q36921437-A59561E0-1E9B-4627-B818-4B9FA0EE6109Q36998804-268673A6-9E5A-4174-BC2B-AD8605A18CB3Q37064910-6774D0AC-7071-4091-843D-4A048B4D12E8Q37122224-BD925369-23BE-4B26-B1C0-BEE5F8D535B3Q37224637-4C3D00D2-8125-4E7C-9A4C-7BA63B18EFF6
P50
description
onderzoeker
@nl
name
Paulette Bioulac-Sage
@ast
Paulette Bioulac-Sage
@en
Paulette Bioulac-Sage
@es
Paulette Bioulac-Sage
@nl
Paulette Bioulac-Sage
@sl
type
label
Paulette Bioulac-Sage
@ast
Paulette Bioulac-Sage
@en
Paulette Bioulac-Sage
@es
Paulette Bioulac-Sage
@nl
Paulette Bioulac-Sage
@sl
prefLabel
Paulette Bioulac-Sage
@ast
Paulette Bioulac-Sage
@en
Paulette Bioulac-Sage
@es
Paulette Bioulac-Sage
@nl
Paulette Bioulac-Sage
@sl
P1006
P214
P1006
P106
P21
P213
0000 0003 8737 2095
P214
P31
P569
2000-01-01T00:00:00Z
P735
P7859
viaf-280320292